It was announced in the recent CEO newsletter. They aim to have 120 centers online while doing the trial. Probably there is some overlap with EPP.
Ann: New case of SCENESSE efficacy in vitiligo presented at AAD, page-13
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.53 |
Change
-0.190(1.29%) |
Mkt cap ! $728.6M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.00 | $14.52 | $165.8K | 11.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 273 | $14.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.55 | 96 | 10 |
View Market Depth
| Last trade - 11.09am 09/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |